iBio, Inc. Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	28.67	8.58	14.21	4.3	22.68	77.4
Short-Term Investments	24.03	-	-	-	10.85	19.57
Cash & Short-Term Investments	52.7	8.58	14.21	4.3	33.52	96.97
Cash Growth	651.22%	-39.61%	230.39%	-87.17%	-65.43%	75.96%
Accounts Receivable	-	-	-	-	1	0.43
Other Receivables	-	0.11	-	0.2	-	-
Receivables	-	0.11	0.71	0.2	1	0.43
Inventory	-	-	-	-	-	0.03
Prepaid Expenses	0.67	1.03	0.75	0.66	1.55	2.07
Restricted Cash	-	-	-	3.03	-	-
Other Current Assets	-	-	-	18.07	9	5.1
Total Current Assets	53.37	9.72	15.67	26.26	45.07	104.6
Property, Plant & Equipment	5.31	5.28	6.37	7.55	4.44	34.74
Other Intangible Assets	4.34	6.85	5.37	5.39	4.85	0.95
Other Long-Term Assets	0.24	0.24	0.24	0.3	43.41	5.18
Total Assets	64.39	23.19	28.73	41.21	99.41	146.97
Accounts Payable	2.65	2.19	0.36	1.85	4.26	2.25
Accrued Expenses	1.58	1.35	2.03	4.56	3.76	3
Short-Term Debt	-	-	0.12	12.94	22.16	-
Current Portion of Long-Term Debt	-	0.77	0.22	-	-	0.6
Current Portion of Leases	0.52	0.61	0.91	0.82	0.09	0.37
Current Unearned Revenue	1.15	1.2	0.2	-	0.1	0.42
Other Current Liabilities	-	-	-	1.94	0.06	-
Total Current Liabilities	5.9	6.11	3.84	22.11	30.44	6.65
Long-Term Debt	-	-	0.77	-	-	-
Long-Term Leases	1.93	2.2	2.8	3.72	3.51	31.76
Other Long-Term Liabilities	-	-	-	-	1.97	-
Total Liabilities	7.83	8.31	7.41	25.83	35.92	38.4
Common Stock	0.03	0.02	0.01	0	0.01	0.01
Additional Paid-In Capital	403.46	347.09	335.16	304.32	287.62	282.27
Retained Earnings	-346.94	-332.22	-313.85	-288.94	-223.93	-173.63
Comprehensive Income & Other	0.01	-	-	-	-0.21	-0.06
Total Common Equity	56.56	14.88	21.32	15.38	63.49	108.59
Minority Interest	-	-	-	-	-	-0.02
Shareholders' Equity	56.56	14.88	21.32	15.38	63.49	108.57
Total Liabilities & Equity	64.39	23.19	28.73	41.21	99.41	146.97
Total Debt	2.45	3.57	4.82	17.48	25.77	32.72
Net Cash (Debt)	50.25	5.01	9.39	-13.17	7.76	64.25
Net Cash Growth	2121.40%	-46.62%	-	-	-87.93%	189.37%
Net Cash Per Share	3.12	0.48	2.45	-21.53	17.78	164.22
Filing Date Shares Outstanding	34.54	19.65	8.64	1.38	0.45	0.44
Total Common Shares Outstanding	30.05	19.35	8.62	1.02	0.44	0.44
Working Capital	47.47	3.62	11.83	4.15	14.63	97.95
Book Value Per Share	1.88	0.77	2.47	15.15	145.49	249.19
Tangible Book Value	52.22	8.03	15.96	9.99	58.63	107.63
Tangible Book Value Per Share	1.74	0.42	1.85	9.84	134.37	247.01
Buildings	0.7	0.7	0.7	0.7	-	-
Machinery	4.48	3.96	3.95	3.92	-	4.97
Construction In Progress	0.03	-	-	-	1.37	3.37

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q